Menstrual abnormalities in women with cushing's disease are correlated with hypercortisolemia rather than raised circulating androgen levels

Journal of Clinical Endocrinology and Metabolism

Volumn 83, Issue 9, 1998, Pages 3083-3088

  Lado Abeal, J ^b   Rodriguez Arnao, J ^a   Newell Price, J D C ^a   Perry, L A ^a   Grossman, A B ^a   Besser, G M ^a   Trainer, P J ^a  

^a ST BARTHOLOMEW S HOSPITAL   (United Kingdom)

^b HOSPITAL CLÍNICO UNIVERSITARIO   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN; ANDROSTENEDIONE; CORTICOTROPIN; ESTRADIOL; FOLLITROPIN; GONADORELIN; HYDROCORTISONE; LUTEINIZING HORMONE; PRASTERONE SULFATE; PROLACTIN; SEX HORMONE BINDING GLOBULIN; TESTOSTERONE;

ADOLESCENT; ADULT; AMENORRHEA; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CUSHING DISEASE; FEMALE; HUMAN; HYPERCORTISOLISM; HYPERMENORRHEA; MENSTRUATION DISORDER; OLIGOMENORRHEA; PRIORITY JOURNAL;

ADOLESCENT; ADULT; ANDROGENS; ANDROSTENEDIONE; CUSHING SYNDROME; DEHYDROEPIANDROSTERONE SULFATE; ESTRADIOL; FEMALE; FOLLICLE STIMULATING HORMONE; HUMANS; HYDROCORTISONE; LUTEINIZING HORMONE; MENSTRUATION DISTURBANCES; PROLACTIN; REFERENCE VALUES; SEX HORMONE-BINDING GLOBULIN; TESTOSTERONE;

EID: 0031773511     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.83.9.3083     Document Type: Article

References (59)

1. Plotz CM, Knowlton AI, Ragan C. 1952 The natural history of Cushing's syndrome. Am J Med 13:597-614.
2. Sprague RG, Randall RV, Salassa RM. 1956 Cushing's syndrome: a progressive and often fatal disease. A review of 100 cases seen between July 1945 and July 1954. Arch Intern Med. 98:389-398.
3. Soffer LJ, Iannaccone A, Gabrilove JL. 1961 Cushing's syndrome. A study of fifty patients. Am J Med. 300:129-146.
4. Urbanic RC, George JM. 1981 Cushing's disease-18 years' experience. Medicine. 60:14-24.
5. Ross EJ, Linch DC. 1982 Cushing's syndrome-killing disease: discriminatory value of signs and symptoms aiding early diagnosis. Lancet. 2:646-649.
6. Nelson DH. 1989 Cushing's syndrome. In: DeGroot LJ, Besser GM, Cahill Jr GF, et al., eds. Endocrinology. Philadelphia: Saunders; 1660-1675.
7. Dubey AK, Plant TM. 1985 A suppression of gonadotropin secretion by cortisol in castrated male rhesus monkeys (Macaca mulatta) mediated by the interruption of hypothalamic gonadotropin-releasing hormone release. Biol Reprod. 33:423-431.
8. Ahima RS, Harlan RE. 1992 Glucocorticoid receptors in LHRH neurons. Neuroendocrinology. 56:845-850.
9. Trainer PJ, Grossman A. 1991 Review-the diagnosis and differential diagnosis of Cushing's syndrome. Clin Endocrinol (Oxf). 34:317-330.
10. Newell-Price J, Trainer P, Perry L, Wass J, Grossman A, Besser M. 1995 A single sleeping midnight cortisol has 100% sensitivity for the diagnosis of Cushing's syndrome. Clin Endocrinol (Oxf). 43:545-550.
11. Howlett TA, Drury PL, Perry L, Doniach I, Rees LH, Besser GM. 1986 Diagnosis and management of ACTH-dependent Cushing's syndrome: comparison of the features in ectopic and pituitary ACTH production. Clin Endocrinol (Oxf). 24:699-713.
12. Grossman AB, Howlett TA, Perry L, et al. 1988 CRF in the differential diagnosis of Cushing's syndrome: a comparison with the dexamethasone suppression test. Clin Endocrinol (Oxf). 29:167-178.
13. Jenkins PJ, Trainer PJ, Plowman PN, et al. 1995 The long-term outcome after adrenalectomy and prophylactic pituitary radiotherapy in adrenocorticotropin-dependent Cushing's syndrome. J Clin Endocrinol Metab. 80:165-171.
14. Besser GM, McNeilly AS, Anderson DC, et al. 1972 Hormonal responses to synthetic luteinizing hormone and follicle stimulating hormone-releasing hormone in man. Br Med J. 3:267-271.
15. Mortimer CH, Besser GM, McNeilly AS, et al. 1973 Luteinizing hormone and follicle stimulating hormone-releasing hormone test in patients with hypothalamic-pituitary-gonadal dysfunction. Br Med J. 4:73-77.
16. Cunnah D, Jessop DS, Besser GM, Rees LH. 1987 Measurement of circulating corticotrophin-releasing factor in man. J Endocrinol. 113:123-131.
17. Wathen NC, Perry LA, Rubenstein E, Chard T. 1987 A relationship between sex hormone binding globulin and dehydroepiandrosterone sulfate in normally menstruating females. Gynecol Endocrinol. 1:47-50.
18. Fattah DI, Chard T. 1981 Simplified method for measuring sex-hormone binding globulin. Clin Chem. 27:1277-1279.
19. Rees LH, Cook DM, Kendall JW, et al. 1971 A radioimmunoassay for rat plasma ACTH. Endocrinology. 89:254-261.
20. Trainer PJ, Lawrie HS, Verhelst J, et al. 1993 Transsphenoidal resection in Cushing's disease-undetectable serum cortisol as the definition of successful treatment. Clin Endocrinol. 38:73-78.
21. Carney JA. 1995 The search for Harvey Cushing's patient, Minnie G, and the cause of her hypercortisolism. Am J Surg Pathol. 19:100-108.
22. Franks S. 1995 Polycystic ovary syndrome [Review]. N Engl J Med. 333:853-861.
23. McKenna TJ, Cunningham SK. 1995 Adrenal androgen production in polycystic ovary syndrome. Eur J Endocrinol. 133:383-389.
24. Iannaccone A, Gabrilove JL, Sohval AR, Soffer LJ. 1959 The ovaries in Cushing's syndrome. N Engl J Med. 261:775-780.
25. Graf MA, Bielfeld P, Distler W, Weiers C, Kuhn-Velten WN. 1993 Pulsatile luteinizing hormone secretion pattern in hyperandrogenemic women. Fertil Steril. 59:761-767.
26. Dunaif A. 1995 Hyperandrogenic anuvulation (PCOS): a unique disorder of insulin action associated with an increased risk of non-insulin-dependent diabetes mellitus [Review]. Am J Med. 98:33S-39S.
27. Boccuzzi G, Angeli A, Bisbocci D, Fonzo D, Giadano GP, Ceresa F. 1975 Effect of synthetic luteinizing hormone releasing hormone (LH-RH) on the release of gonadotropins in Cushing's disease. J Clin Endocrinol Metab. 40:892-895.
28. Luton JP, Thieblot P, Valcke JC, Mahoudeau JA, Bricaire H. 1977 Reversible gonadotropin deficiency in male Cushing's disease. J Clin Endocrinol Metab. 45:488-495.
29. Thieblot P, Luton JP, Mahoudeau J, Simon D, Bricaire H. 1979 Etude de la fonction gonadotrope dans le syndrome de Cushing chez la femme. Ann Endocrinol (Paris). 40:429-430.
30. Thieblot P, Luton JP, Mahoudeau J, Bricaire H. 1979 La fonction gonadotrope dans le syndrome de Cushing chez la femme. Ann Endocrinol (Paris). 40:3-14.
31. White MC, Sanderson J, Mashiter K, Joplin GF. 1981 Gonadotrophin levels in women with Cushing's syndrome before and after treatment. Clin Endocrinol (Oxf). 14:23-29.
32. Odagiri E, Yamanaka Y, Ishiwatari N, et al. 1988 Studies on pituitary-gonadal function in patients with Cushing's syndrome. Endocrinol Jpn. 35:421-427.
33. Cuerda C, Estrada J, Marazuela M, et al. 1991 Anterior pituitary function in Cushing's syndrome: study of 36 patients. Endocrinol Jpn. 38:559-563.
34. Hayashi KT, Moberg GP. 1990 Influence of the hypothalamic-piluitary-adrenal axis on the menstrual cycle and the pituitary responsiveness to estradiol in the female rhesus monkey (Macaca mulatta). Biol Reprod. 42:260-265.
35. Veldhuis JD, Lizarralde G, Iranmanesh A. 1992 Divergent effects of short term glucocorticoid excess on the gonadotropic and somatotropic axes in normal men. J Clin Endocrinol Metab. 74:96-102.
36. Saketos M, Sharma N, Santoro NF. 1993 Suppression of the hypothalamic-pituitary-ovarian axis in normal women by glucocorticoids. Biol Reprod. 49:1270-1276.
37. Samuels MH, Luther M, Henry P, Ridgway EC. 1994 Effects of hydrocortisone on pulsatile pituitary glycoprotein secretion. J Clin Endocrinol Metab. 78:211-215.
38. Olster DH, Ferin M. 1987 Corticotropin-releasing hormone inhibits gonadotropin secretion in the ovariectomized rhesus monkey. J Clin Endocrinol Metab. 65:262-267.
39. Xiao E, Luckhaus J, Niemann W, Ferin M. 1989 Acute inhibition of gonadotropin secretion by corticotropin-releasing hormone in the primate: are the adrenal glands involved? Endocrinology. 124:1632-1637.
40. Barbarino A, De Marinis L, Tofani A, et al. 1989 Corticotropin-releasing hormone inhibition of gonadotropin release and the effect of opioid blockade. J Clin Endocrinol Metab. 68:523-528.
41. Barbarino A, De Marinis L, Folli G, et al. 1989 Corticotropin-releasing hormone inhibition of gonadotropin secretion during the menstrual cycle. Metabolism. 38:504-506.
42. Fischer UG, Wood SH, Bruhn J, et al. 1992 Effect of human corticotropin-releasing hormone on gonadotropin secretion in cycling and postmenopausal women. Fertil Steril. 58:1108-1112.
43. Yanovski JA, Cutler GB, Chrousos GP, Nieman LK. 1993 Corticotropin-releasing hormone stimulation following low-dose dexamethasone administration-a new test to distinguish Cushing's syndrome from pseudo-Cushing's states. JAMA. 269:2232-2238.
44. Caufriez A, Desir D, Szyper M, Robyn C, Copinschi G. 1981 Prolactin secretion in Cushing's disease. J Clin Endocrinol Metab. 53:843-846.
45. Comtois R, Beauregard H, Hardy J, Robert F, Somma M. 1993 High prolactin levels in patients with cushing's disease without pathological evidence of pituitary adenoma. Clin Endocrinol (Oxf). 38:601-607.
46. Yamaji T, Ishibashi M, Teramoto A, Fukushima T. 1984 Hyperprolactinemia in Cushing's disease and Nelson's syndrome. J Clin Endocrinol Metab. 58:790-795.
47. Jeffcoate WJ, Rees LH, Tomlin S, Jones AE, Edwards CR, Besser GM. 1977 Metyrapone in long-term management of Cushing's disease. Br Med J. 2:215-217.
48. Verhelst JA, Trainer PJ, Howlett TA, et al. 1991 Short and long-term responses to metyrapone in the medical management of 91 patients with Cushing's syndrome. Clin Endocrinol (Oxf). 35:169-178.
49. Rossmanith WG, Schenkel B, Benz R. 1994 Role of androgens in the regulation of the human menstrual cycle. Gynecol Endocrinol. 8:151-159.
50. Couzinet B, Schaison G. 1993 The control of gonadotrophin secretion by ovarian steroids [Review]. Hum Reprod. 8(Suppl 2):97-101.
51. Amirikia H, Savoy-Moore RT, Sundareson AS, Moghissi KS. 1986 The effects of long-term androgen treatment on the ovary. Fertil Steril. 45:202-208.
52. Futterweit W, Deligdisch L. 1986 Histopathological effects of exogenously administered testosterone in 19 female to male transsexuals. J Clin Endocrinol Metab. 62:16-21.
53. Spinder T, Spijkstra JJ, van den Tweel JG, et al. 1989 The effects of long term testosterone administration on pulsatile luteinizing hormone secretion and on ovarian histology in eugonadal female to male transsexual subjects. J Clin Endocrinol Metab. 69:151-157.
54. Dunaif A, Scully RE, Andersen RN, Chapin DS, Crowley Jr WF. 1984 The effects of continuous androgen secretion on the hypothalamic-piluitary axis in woman: evidence from a luteinized thecoma of the ovary. J Clin Endocrinol Metab. 59:389-393.
55. Pascale MM, Pugeat M, Roberts M, et al. 1994 Androgen suppressive effect of GnRH agonist in ovarian hyperthecosis and virilizing tumours. Clin Endocrinol (Oxf). 41:571-576.
56. Chico A, Garcia JL, Matias-Guiu X, et al. 1995 A gonadotrophin dependent stromal luteoma: a rare cause of post-menopausal virilization. Clin Endocrinol (Oxf). 43:645-649.
57. Spinder T, Spijkstra JJ, Gooren LJ, Hompes PG, van Kessel H. 1989 Effects of long-term testosterone administration on gonadotropin secretion in agonadal female to male transsexuals compared with hypogonadal and normal women. J Clin Endocrinol Metab. 68:200-207.
58. Dewis P, Newman M, Ralcliffe WA, Anderson DC. 1986 Does testosterone affect the normal menstrual cycle? Clin Endocrinol (Oxf). 24:515-521.
59. Smith EP, Boyd J, Frank GR, et al. 1994 Estrogen resistance caused by a mutation in the estrogen-receptor gene in a man. N Engl J Med. 331:1056-1061.